Trending...
- EFLOW FX Introduces Multi-Family Real Estate Investment Plan Accepting Crypto and Fiat Investors
- Partnershoring: Pioneering Strategic Collaboration for Commercial Success in the New Economy
- Josh Weil Announces Campaign for Congress in Florida's 6th District
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Floridant -- The ROS1ders announced the recipient of the 2024 Eunice and Milton Ring Grant for ROS1 Cancer Research. Funding for this grant is provided by Eunice and Milton Ring, whose daughter Karen Ring Weiss is a member of the ROS1+ cancer community.
The 2024 award was granted to Anthony Iafrate, MD, Ph.D, Professor of Pathology at Harvard Medical School and Vice Chair of Academic Affairs at the Massachusetts General Hospital. Dr. Iafrate's team is seeking new approaches to targeting ROS1+ fusion cancers that can overcome acquired resistance to current targeted therapies. They aim to identify regions of ROS1 fusion proteins that can be attacked with covalent inhibitors, which may lead to new treatments.
"Patient advocacy calls attention to the need for research about specific cancer biomarkers," says Eunice Ring. "Because ROS1+ cancer is rare, patients and their families must provide leadership in research focused on their cancer. We are very pleased to support Dr. Iafrate's team."
More on The Floridant
This grant is the third in a series of seed grants focused on ROS1+ cancers. Janet Freeman-Daily, co-founder and president of the ROS1ders, says "Our ROS1+ cancer community is grateful that biomarker testing and targeted therapy have added years to so many lives. However, the currently approved drugs don't work well for everyone. We hope our seed grants will generate findings that lead to larger research efforts and better outcomes."
About the ROS1ders
Founded by patients, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1,100 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on The Floridant
About ROS1+ Cancer
The 2024 award was granted to Anthony Iafrate, MD, Ph.D, Professor of Pathology at Harvard Medical School and Vice Chair of Academic Affairs at the Massachusetts General Hospital. Dr. Iafrate's team is seeking new approaches to targeting ROS1+ fusion cancers that can overcome acquired resistance to current targeted therapies. They aim to identify regions of ROS1 fusion proteins that can be attacked with covalent inhibitors, which may lead to new treatments.
"Patient advocacy calls attention to the need for research about specific cancer biomarkers," says Eunice Ring. "Because ROS1+ cancer is rare, patients and their families must provide leadership in research focused on their cancer. We are very pleased to support Dr. Iafrate's team."
More on The Floridant
- OneSolution® Dental Implant Centers Offers Advanced Zygomatic Dental Implant Solutions
- Magazine features Pink and Main in its December issue
- Unbeatable Value Sponsorship Opportunity Announced for Love Eat Travel Series on PBS
- Kuruma Imports Hosting Toys For Tots Car Meet to Spread Holiday Cheer
- Francesca Corbi Joins Coral Bay Recovery Clinical Team
This grant is the third in a series of seed grants focused on ROS1+ cancers. Janet Freeman-Daily, co-founder and president of the ROS1ders, says "Our ROS1+ cancer community is grateful that biomarker testing and targeted therapy have added years to so many lives. However, the currently approved drugs don't work well for everyone. We hope our seed grants will generate findings that lead to larger research efforts and better outcomes."
About the ROS1ders
Founded by patients, The ROS1ders is the largest global group of patients and family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Membership in their private Facebook group exceeds 1,100 people from over 30 countries. The nonprofit is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Its resources include a medically-vetted website and collaboration with international ROS1+ clinicians, researchers and industry. Please visit theros1ders.org to learn more.
More on The Floridant
- "Transform Your Look with Expert Hair, Skin, and Beauty Services at McAllister Spa!"
- Security Experts to Host Conference on Deepfakes and Cybersecurity in 2025
- Pittsburgh Professional Women invites all Women and Allies to MONEY CLUB
- Speranza Dental Implant Center's New Website Launch!
- Education Through Music-Los Angeles to Host 19th Year Benefit Gala on Friday December 6th at Skirball Cultural Center
About ROS1+ Cancer
- ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer (NSCLC). The incidence is thought to be similar in other types of cancer.
- Biomarker testing for ROS1 fusions is recommended in guidelines for non-small cell lung cancer, but currently for few other cancers.
- Patients are typically younger than the average NSCLC patient, have adenocarcinoma, and have no smoking history (a smoking history should not exclude patients from biomarker testing or targeted therapies).
- Oral targeted therapies are the recommended first-line treatment for metastatic ROS1+NSCLC and have increased the survival of patients by years. However, these drugs eventually stop working due to acquired resistance. The mechanisms of resistance are not well understood.
Source: The ROS1ders
0 Comments
Latest on The Floridant
- Extol, with Beadworx and Beyond Borders, Joins Fair Trade Federation to Champion Ethical Practices
- What To Know About Moving To The Middle & Upper Florida Keys
- Super Bowl champion QB Joe Theismann to speak at NAMI Collier County's 2025 Hope Shin
- Start Fresh in 2025: Florida Law Office Offers Affordable Bankruptcy Solutions and Statewide Virtual Q&A
- LRP's National Institute Announces Nine Engaging Extended-Length Symposiums
- Is This the Safest Way to Get Rich in Crypto? Experts Say Yes
- "Federal Complaint Filed: David Medeiros Uncovers Medicaid Mismanagement, ADA Violations, and Systemic Failures in Connecticut"
- Introducing Feelness: A Revolutionary Solution for Physical Self-Care Without the Fitness Lifestyle
- Omnitronics Wins Software Combined 2024 AI Innovation Award
- Altruistic Academy Hosts Friends & Family Event with Free CPR Training December 19th
- Lux Boutique Unveils Exclusive Resort Wear Collection for Vacationers in Naples, FL
- Countryside Golf & Country Club general manager receives prestigious professional designation
- Top Beauty Salon in Miami Beach – Hair, Nails, Skincare & More!
- Miami Beach's Best Hair Salon & Beauty Spa – Book Your Appointment Today!
- Mrs Elemental® USA Rebrands to Empower Married Women Across the Nation
- GET A GRIP Resurfacing Franchise Opens in Tampa
- New from Down & Out Books: MICKEY FINN VOL. 5 edited by Michael Bracken
- Sip, Snack and Celebrate: Red Lobster Announces Launch of Happy Hour
- ioTech International Launches ioRinse™MR: A Revolutionary Oral Rinse Providing Essential Relief For Cancer Patients Facing Oral Side Effects
- Better Together receives $15,000 from Gulf Coast Community Foundation to support hurricane relief